Hallux Valgus Market
DelveInsight’s ‘Hallux Valgus (Bunion)-Market Insights, Epidemiology and Market Forecast—2030’ report delivers an in-depth understanding of the Hallux Valgus, historical and forecasted epidemiology as well as the Hallux Valgus market trends in the United States, EU-5 (Germany, France, Italy, Spain, and United Kingdom), and Japan.
The Hallux Valgus market report provides current treatment practices, emerging drugs, Hallux Valgus market share of the individual therapies, current and forecasted Hallux Valgus market size from 2017 to 2030 segmented by seven major markets. The Report also covers current Hallux Valgustreatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.
• The United States
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
Study Period: 2017–2030
Hallux Valgus (Bunion): Disease Understanding and Treatment Algorithm
Hallux Valgus Overview
Hallux valgus, commonly known as a Bunion, is one of the most common progressive forefoot deformities across the globe. A bunion is basically a “bump” which develops at the joint of the big toe—the metatarsophalangeal (MTP) joint. The big toe is made up of two joints. The larger of the two is the MTP, where the first long bone of the foot (metatarsal) meets the first bone of the toe (phalanx). Bump formation happens slowly over long period of time and finally progresses when the bone or tissue at the big toe joint moves out of alignment. Many women wear tight, narrow shoes that squeeze the toes together, creating favorable conditions for a bunion to develop, deteriorate, and cause painful symptoms. Apart from wearing tight-narrow shoes, heredity and other inflammatory condition, such as rheumatoid arthritis or a neuromuscular condition, such as polio, cause bunion in an individual. Clinically, bunions are classified into three types, mild, moderate, and severe. Hallux valgus severity can be defined as the angulation of the big toe at the first metatarsophalangeal joint and classified as mild (20°–30°), moderate (30°–40°) and severe (>40°). Bunions can occur in any gender or age group, but they are most commonly observed in women and the elderly.
Hallux Valgus Diagnosis
For diagnosis purpose, the doctor begins with a physical examination while asking questions related to medical history, general health, and other symptoms of the patient. Although bunion can be easily diagnosed on the basis of symptoms and visibility of a bump but still for better understanding doctor probably asks the patient to get an X-ray done, on the basis of X-ray, two angles are assessed extensively;
Intermetatarsal angle – the angle between the first and second metatarsals (the bones that lead up to the bases of the big toe and second toe). If this angle is wider than nine degrees (9º), it is abnormal and referred to as metatarsus primus varus.
Hallux valgus angle – the angle of the big toe as it drifts toward the small toe. An angle that exceeds 15º is considered to be a sign of hallux valgus.
Hallux Valgus Treatment
The therapy choices for bunions comprises self-care, numerous pain-relieving medications, medical devices, and the most important one, Surgery. Although, the kind of treatment suggested to the patient entirely depends upon the severity of the condition. Non-operative or non-surgical type of treatment would not help a patient in eradicating the deformity but it does help in getting relief from the symptoms for a defined period of time, and if the pain persists even after trying all these methods, the patient is advised to go for the surgery.
Hallux Valgus (Bunion) Epidemiology
The Hallux Valgus epidemiology division provides the insights about historical and current Hallux Valgus patient pool and forecasted trend for each seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
The disease epidemiology covered in the report provides historical as well as forecasted Hallux Valgus epidemiology [segmented as Total Prevalent Cases of Hallux Valgus (by Age), Total Diagnosed Prevalent Cases of Hallux Valgus, Gender-specific prevalent case of Hallux Valgus, Severity-specific prevalent cases of Hallux Valgus, Treated cases of Hallux Valgus] scenario of Hallux Valgus in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017 to 2030.
Country Wise-Hallux Valgus Epidemiology
• In the year 2017, the total prevalent cases of Hallux Valgus were 172,039,751 in the 7MM. In the 7MM, among all the age groups 11,973,464 cases were accounted for less than 18 years, whereas for the age group 18–65 years and more than 65 years accounted for 109,690,287 and 50,376,000 number of cases for the year 2017.
• The United States, in 2017, accounted for 70,259,180 cases (the highest number among the 7MM countries).
• Among the EU-5 countries, the highest number of cases of Hallux Valgus were in Germany, i.e., 18,748,873 cases in the year 2017, which is estimated to rise by the year 2030.
• Spain accounted for the least number of prevalent cases, i.e., 11,229,531 cases in 2017.
• Among the 7MM, Japan accounted for 28,351,056 cases, respectively in 2017.
Hallux Valgus (Bunion) Device Chapters
Drug chapter segment of the Hallux Valgus report encloses the detailed analysis of Hallux Valgus marketed drugs. Talking about the emerging situation, limited activity has been observed and the relevant current emerging therapies are focusing on the symptomatic relief (i.e., pain relief) and not treating the actual underlying cause. For pain relief, medication like NSAIDs and other analgesics abundantly present in the market, thereby forecast of these therapies in our bunion model is not considered. It also helps to understand the Hallux Valgus clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.
Hallux Valgus Marketed Devices
Magnezix CS: Syntellix
Magnezix, world's first bioabsorbable metallic material for implants is a magnesium alloy (MgYREZr) with stable metallic properties but which can be completely bioresorbed in the body and replaced by endogenous tissue. Experimental studies have confirmed that magnesium has an osteoconductive effect and tends to inhibit infection. The alloy from the MgYREZr alloy system pursuant to DIN EN 1753 has a magnesium content of over 90%, a grain size of less than 10 µm, and is manufactured using a so-called powder metallurgical process. This enables it to achieve a tensile strength which is much higher than that of the polymers (PLA/PGA) and lies in the range between bone and titanium. As a material for implants for osteosynthesis, this is an ideal combination of properties for providing temporary support. The mechanical properties are very similar to those of human bone. Syntellix offers a range of implants which include, Magnezix Compression Screws, Pins, CBS, and Starfuse
Lapiplasty 3-Dimensional Bunion Correction: Treace Medical Concepts
Developed by Treace Medical Concepts, Lapiplasty 3-Dimensional Bunion Correction is a novel, advanced technology used to correct bunions surgically. Lapiplasty is the first and only procedure specifically developed to correct all 3-dimensions of the bunion deformity, at the root of the problem. Rather than cutting and shifting the bone over as traditional 2D surgery does, it uses advanced instrumentation to precisely reposition the entire misaligned bone back into normal 3D alignment, naturally removing the bump and straightening the toe.
PROstep Minimally Invasive Surgery System: Wright Medical Technology
Developed by Wright Medical Technology, PROstep is a minimally invasive surgical (MIS) technique. PROstep Minimally-Invasive Foot and Ankle system and MICA are designed on the premise that all “current” procedures can be performed through a smaller, minimally invasive, incision, with a focus on preserving the soft tissues. It comprises of MICA Screws, PROstep Power Box, PROstep Burrs, and instruments to perform minimally invasive procedures such as Chevron, Akin, Bunionectomy, and Bunionette.
Minimally Invasive Bunion (M.I.B.) Plating System: Trilliant Surgical
The Minimally Invasive Bunion (M.I.B.) Plating System is a special solution to triplanar hallux valgus correction. The M.I.B. installation allows for simultaneous adjustment by using a transverse osteotomy in the frontal, transverse, and sagittal planes. Multi-directional contraction as well as stabilization of the osteotomy is accomplished by using 2.4mm distal locking screws in combination with two anti-rotational, crossing, interfrag screws.
KISSloc Suture System: Arthrosurface
Arthrosurface’s KISSloc Suture System is a mini plate and suture implant designed to correct a Hallux Valgus deformity. This simple, strong and fast fixation system consists of two low-profile titanium plates and a self-clinching suture construct, which corrects Hallux Valgus by reducing the intramedullary angle between the first and second metatarsal bones. The small 1.2 mm bone tunnels significantly reduce the stress on the bone caused by larger holes while the low-profile plates distribute the load across a larger area. KISSloc allows accurate tunnel placement, uses strong suture, and the self-clinching feature adjusts the correct angle for each patient individually. Suture Plate and Arrow Plate are made up of Ti-6AL-4V ELI Titanium Alloy whereas, material used in making Suture Construct is #5 UHMWPE Braided Fiber. Apart from this, it can be placed proximally or distally and locks motion in the coronal plane while still allowing sagittal motion.
Axi+Line Proximal Bunion Correction System: Nextremity Solutions
The Axi+Line Proximal Bunion Correction System is a plate system made from Titanium alloy, being used in addressing the treatment of deformities of larger angles and addresses along with making corrections in the frontal plane. The geometry of the plate is that of a modified semi-tubular bone plate with a correction angle between the proximal and distal plate segments. The system also includes non-locking cortical and locking screws also made from Titanium alloy and necessary surgical site preparation and insertion instruments as a procedure pack. It provides surgeons with a great option between a distal approach and a Lapidus approach
Products detail in the report…
Hallux Valgus (Bunion) Market Outlook
According to DelveInsight, Hallux Valgus market in the 7MM is expected to change in the study period 2017–2030.The therapeutic market of Hallux Valgus in seven major markets was found to be USD 6,254 million in 2017 which is expected to increase during study period (2017–2030).
The United States Market Outlook
In 2017, the total market size of Hallux Valgus therapies was found to be USD 2,696 million in the United States which is expected to increase in the study period (2017–2030).
EU-5 Countries: Market Outlook
In 2017, the total market size of Hallux Valgus therapies was found to be USD 2,567 million in the EU-5 countries which is expected to increase in the study period (2017–2030).
Japan Market Outlook
The total market size of Hallux Valgus therapies in Japan was found to be USD 991 million in 2017.
Hallux Valgus (Bunion) Pipeline Development Activities
Inadequate pipeline activity has been observed for Hallux Valgus, and a few current emerging therapies are focusing on the symptomatic relief (i.e., pain relief) and not treating the actual underlying cause. For pain relief, medication like NSAIDs and other analgesics abundantly present in the market, thereby forecast of these therapies is not considered.
Access and Reimbursement Scenario in Hallux Valgus (Bunion) Therapies
• In the United States, the average cost of bunion surgery is around USD 5,500, but it can range from USD 3,500 to 12,000. This number depends on the area, the type of treatment, insurance coverage they have, and the overall health. That is why Part B of Medicare is helpful. Medicare’s Section B provides coverage in a doctor’s office or hospital environment for medically required care and supplies. As long as the doctor supports the assignment, the patients will have compensation for podiatrist foot examinations.
• In United Kingdom, procedures are not funded for cosmetic reasons or asymptomatic or mildly symptomatic. Surgery for hallux valgus will be funded if the following criteria are met and evidenced in clinic letters. In addition, surgery will also be funded if there is significant and persistent pain when walking and conservative measures tried for at least 6-months (e.g., Toe spacers, bunion pads medication, or altered footwear) do not provide symptomatic relief.
To keep up with current market trends, we take KOLs and SME’s opinion working in Hallux Valgus domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Hallux Valgus market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs
Hallux Valgus (Bunion) Uptake
Lapiplasty is 3D bunion correction system with, low reoccurrence rate. Recently (i.e., 2019) label expansion for pediatric patients greater than 12 years of age is given by US FDA. This candidate will have early mover advantage and is expected to grab the comparatively higher market share followed by PROstep.
Competitive Intelligence Analysis
We perform Competitive and Market Intelligence analysis of the Hallux Valgus Market by using various Competitive Intelligence tools that includes – SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.
Scope of the Report
• The report covers the descriptive overview of Hallux Valgus, explaining its causes, signs and symptoms, pathophysiology and currently available therapies.
• Comprehensive insight has been provided into the Hallux Valgus epidemiology and treatment in the 7MM.
• Additionally, an all-inclusive account of both the current therapies for Hallux Valgus are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape.
• A detailed review of Hallux Valgus market; historical and forecasted is included in the report, covering drug outreach in the 7MM.
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Hallux Valgus market.
• In the coming years, Hallux Valgus market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market.
• The companies and academics are working to assess challenges and seek opportunities that could influence Hallux Valgus R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition.
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Hallux Valgus.
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities.
Hallux Valgus (Bunion) Report Insights
• Patient Population
• Therapeutic Approaches
• Hallux Valgus Pipeline Analysis
• Hallux Valgus Market Size and Trends
• Market Opportunities
Hallux Valgus (Bunion) Report Key Strengths
• 11 Years Forecast
• 7MM Coverage
• Hallux Valgus Epidemiology Segmentation
• Key Cross Competition
• Highly Analyzed Market
• Drugs Uptake
Hallux Valgus (Bunion) Report Assessment
• SWOT Analysis
• Current Treatment Practices
• Unmet Needs
• Market Attractiveness
• Market Drivers and Barriers
• What was the Hallux Valgus Market share (%) distribution in 2017 and how it would look like in 2030?
• What would be the Hallux Valgus total market Size as well as market size by therapies across the 7MM during the study period (2017–2030)?
• What are the key findings pertaining to the market across the 7MM and which country will have the largest Hallux Valgus market size during the study period (2017–2030)?
• At what CAGR, the Hallux Valgus market is expected to grow in the 7MM during the study period (2017–2030)?
• What would be the Hallux Valgus market outlook across the 7MM during the study period (2017–2030)?
• What would be the Hallux Valgus market growth till 2030 and what will be the resultant market size in the year 2030?
• How would the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?
• Hallux Valgus patient types/ pool where unmet need is more and whether emerging therapies will be able to address the residual unmet need?
• How emerging therapies are performing on the parameters like efficacy, safety, route of administration (RoA), treatment duration and frequencies based on their clinical trial results?
• Among the emerging therapies, what are the potential therapies which are expected to disrupt the Hallux Valgus market?
• What is the disease risk, burden and unmet needs of the Hallux Valgus?
• What is the historical Hallux Valgus patient pool in seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan?
• What would be the forecasted patient pool of Hallux Valgus in 7 major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan?
• What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Hallux Valgus?
• Out of all the 7MM countries, which country would have the highest prevalent population of Hallux Valgus during the study period (2017–2030)?
• At what CAGR the population is expected to grow in the 7MM during the study period (2017–2030)?
• What are the various recent and upcoming events which are expected to improve the diagnosis of Hallux Valgus?
Current Treatment Scenario, Marketed Drugs and Emerging Therapies:
• What are the current options for the treatment of Hallux Valgus along with the approved therapy?
• What are the current treatment guidelines for the treatment of Hallux Valgus in the US, Europe and Japan?
• What are the Hallux Valgus marketed drugs and their MOA, regulatory milestones, product development activities, advantages, disadvantages, safety and efficacy, etc.?
• How many companies are developing therapies for the treatment of Hallux Valgus?
• How many therapies are developed by each company for the treatment of Hallux Valgus?
• How many emerging therapies are in mid stage, and late stage of development for the treatment of Hallux Valgus?
• What are the key collaborations (Industry–Industry, Industry–Academia), Mergers and acquisitions, licensing activities related to the Hallux Valgus therapies?
• What are the recent novel therapies, targets, mechanisms of action and technologies developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for Hallux Valgus and their status?
• What are the key designations that have been granted for the emerging therapies for Hallux Valgus?
• What are the global historical and forecasted market of Hallux Valgus?
Reasons to buy
• The report will help in developing business strategies by understanding trends shaping and driving the Hallux Valgus market.
• To understand the future market competition in the Hallux Valgus market and Insightful review of the key market drivers and barriers.
• Organize sales and marketing efforts by identifying the best opportunities for Hallux Valgus in the US, Europe (Germany, France, Italy, Spain, and the United Kingdom) and Japan.
• Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.
• Organize sales and marketing efforts by identifying the best opportunities for Hallux Valgus market.
• To understand the future market competition in the Hallux Valgus market.